Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Randomized Amifostine For SCCHN

ClinicalTrials.gov ID: NCT00095927

Public ClinicalTrials.gov record NCT00095927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 2:28 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II, Randomized Study of Concomitant Chemoradiation Using Weekly Carboplatinum/Paclitaxel With (Arm A) or Without (Arm B) Daily Subcutaneous Amifostine in Patients With Newly Diagnosed Locally Advanced Squamous Cell Cancer of the Head and Neck

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This research study is studying a drug called Amifostine as a treatment for squamous cell carcinoma in the head and/or neck area.

Study identification

NCT ID
NCT00095927
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
58 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2003 (Type not available)
Primary completion
Jun 2007 (Actual)
Completion
Jun 2008 (Actual)
Last update posted
Jan 4, 2017

2003 – 2008

United States locations

U.S. sites
9
U.S. states
3
U.S. cities
7
Facility City State ZIP Site status
Goodall Hospital Sanford Maine 04703 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Dana-Farber Cancer Institute Boston Massachusetts 02115 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Bethke Cancer Center at Emerson Hospital Concord Massachusetts 01742 —
Mass General/North Shore Cancer Center Danvers Massachusetts 01923 —
Saint Anne's Hospital - Fall River Fall River Massachusetts 02721 —
Lowell General Hospital Lowell Massachusetts 01854 —
Wentworth Douglass Hospital Dover New Hampshire 03820 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00095927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 4, 2017 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00095927 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →